Ophthalmic Research Assoc is categorized under Commercial Medical Research in Andover, MA and active since 1985.
Ophthalmic Research Assoc was established in 1985, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Mark Abelson, Owner at the company’s single location by writing to 300 Brickstone Square # 1005, Andover, Massachusetts MA 01810 or by phoning (978) 685-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ophthalmic Research Assoc |
Contact Person: | Mark Abelson, Owner |
Address: | 300 Brickstone Square # 1005, Andover, Massachusetts 01810 |
Phone Number: | (978) 685-8900 |
Website Address: | eyedrop.com |
Annual Revenue (USD): | Unknown |
Founded: | 1985 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 5419100 |
Share This Business: |
Ophthalmic Research Assoc was started in 1985 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Mark Abelson, Owner for inquiries that concern Ophthalmic Research Assoc by calling the company number (978) 685-8900, as your correspondence is most welcome. Additionally, the physical location of the single location of Ophthalmic Research Assoc can be found at the coordinates 42.675404,-71.146753 as well as the street address 300 Brickstone Square # 1005 in Andover, Massachusetts 01810.
For its online presence, you may visit Ophthalmic Research Assoc’s website at eyedrop.com and engage with its social media outlets through on Twitter and on Facebook.